Story perspectives

AstraZeneca Invests £300 M in Cambridge, Macclesfield Labs

4/29/2026

Summary

AstraZeneca Invests

AstraZeneca announced a £300 million UK investment on 29 April 2026, reviving a £200 million Cambridge expansion and adding £100 million for Macclesfield.
The Cambridge funds will complete the Rosalind Franklin building.
The Macclesfield funds will build a “lab of the future”.
Prime Minister Keir Starmer said the investment future-proofs jobs and shows confidence after a UK-US trade pact that raises NHS payments by 25 % and lifts US tariffs on UK drug exports.

Summary

AstraZeneca Warns

Companies warn the most-favoured-nation pricing regime could deprive European patients of therapies.
AstraZeneca CEO Pascal Soriot said the U.S.–UK deal is crucial for boosting spending on medicines and expanding access.
Industry observers say the agreement mirrors pricing policies introduced by the Trump administration.
AstraZeneca beat earnings expectations on cancer and rare-disease drug sales after cancelling a £450 million vaccine plant and withdrawing a £200 million Cambridge expansion due to reduced government support.

History

Historical Context

Building on the long-standing UK-US “Special Relationship” dating to 1785, the 2004 Trade and Investment Framework Agreement created a formal channel for pharmaceutical trade. The pact mirrors earlier US-led TIFAs, such as the US-ASEAN arrangement in 2006 and the US-Uruguay TIFA signed in 2007, showing a broader trend of using TIFAs to deepen trans-Atlantic and global investment ties.

1 of 3

AstraZeneca Invests

AstraZeneca announced a £300 million UK investment on 29 April 2026, reviving a £200 million Cambridge expansion and adding £100 million for Macclesfield.
The Cambridge funds will complete the Rosalind Franklin building.
The Macclesfield funds will build a “lab of the future”.
Prime Minister Keir Starmer said the investment future-proofs jobs and shows confidence after a UK-US trade pact that raises NHS payments by 25 % and lifts US tariffs on UK drug exports.

1 / 3